Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-111

Jock

Like most I see a possible upside to this as we have been told ODD response from FDA should hit in the next few months.
We have also been told that the phase 2 mnd trial should commence before June 30.
But being a glass empty person I still see risks, what happens if the FDA rejects the ODD application.
Where are the funds going to come from for the mnd trial.
What happens if the phase 2 trial doesn't start within
the given timeline.
My main reason for being in PAA is human cancer and want to see them back trialling this as per Roger's statement over 12 months ago